Overview
- 98 inspections across 92 sites are on record.
- 213 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-08.
At a glance
Inspections
98
Sites
92
Observations
213
Career since
Jun 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park) | 8 May 2026 | Human Drugs | On file |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 24 Apr 2026 | Human Drugs | On file |
| Human Genome Sciences Inc | 31 Jul 2025 | Human Drugs | On file |
| INTERVEIN RESEARCH LABS PRIVATE LIMITED | 16 May 2025 | Human Drugs | View 483 → |
| Amneal Pharmaceuticals Private | 12 May 2025 | Human Drugs | View 483 → |
Sites inspected
Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park)Jinan, China1 insp.
Zhejiang Huahai Pharmaceutical Co., Ltd.Linhai, China1 insp.
Human Genome Sciences IncRockville, United States1 insp.
INTERVEIN RESEARCH LABS PRIVATE LIMITEDAhmedabad, India1 insp.
Amneal Pharmaceuticals PrivateSanand, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Kejun Cheng3 shared
Hung H Do3 shared
Elaine E Gilfillan3 shared
Amy N Chen3 shared
Shirshendu K Deb3 shared
Jessica L Pressley3 shared
Guerlain Ulysse3 shared
Eileen A Liu2 shared
Pushpa S Jayasekara2 shared
Melanie W Pishnery2 shared
Full investigator report
Get the verbatim findings behind Marcellinus D Dordunoo's 213 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site